Today, Teva- Pharmaceutical Industries Ltd. ADR (NYSE: TEVA) Takes Center Stage

After Hours

The risks associated with pre-market and after-hours trading may be slightly higher than the regular market hours. The reason is that extended-hours trading may result in wider spreads for particular security due to lower liquidity and higher volatility as issuers often announce critical financial information outside regular trading hours.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free
Sponsored

Stocks Info

The company is listed on the NYSE and operates within the Drug Manufacturers – Specialty & Generic industry segment. The current market capitalization of Teva- Pharmaceutical Industries Ltd. ADR is $20.10B. A total of 4.87 million shares were traded on the day, compared to an average of 8.63M shares.

In the most recent transaction, Daniell Richard sold 98,943 shares of TEVA for 17.30 per share on Aug 12 ’24. After the transaction, the Exec. VP, European Commercial now owns 0 company shares. In a previous transaction on Aug 09 ’24, Grant Angus sold 4,065 shares at 17.28 per share. TEVA shares that EVP, Business Development owns now total 8,848.

Among the insiders who sold shares, Hughes Eric A disposed of 45,060 shares on Aug 09 ’24 at a per-share price of $17.38. This resulted in the See “Remarks” holding 0 shares of TEVA after the transaction. In another insider transaction, Daniell Richard bought 98,943 shares at $17.30 per share on Aug 12 ’24.

It has been observed that price targets are rarely accurate, but they can exert some influence from time to time, and are often accepted as valuable in the market. In terms of 52-week highs and lows, TEVA has a high of $19.08 and a low of $8.06.

Balance Sheet Annually/Quarterly

An equity investor’s investment can be viewed on a balance sheet by looking at what assets and liabilities the company has. Investors can determine the company’s prospects by calculating its financial ratios based on this information. TEVA’s latest balance sheet shows that the firm has $2.17B in Cash & Short Term Investments as of fiscal 2021. There were $23.46B in debt and $11.03B in liabilities at the time. Its Book Value Per Share was $5.61, while its Total Shareholder’s Equity was $11.24B.

Analysts Opinion

There may be slightly higher risks associated with pre-market and after-hours trading than during regular market hours. Due to the fact that issuers often announce critical financial information outside of regular trading hours, extended-hours trading may result in wider spreads for particular securities. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for TEVA is Buy with a score of 4.56.

Most Popular

Related Posts